Literature DB >> 10373517

Osmotic shock inhibits insulin signaling by maintaining Akt/protein kinase B in an inactive dephosphorylated state.

D Chen1, R V Fucini, A L Olson, B A Hemmings, J E Pessin.   

Abstract

We have previously reported that insulin and osmotic shock stimulate an increase in glucose transport activity and translocation of the insulin-responsive glucose transporter isoform GLUT4 to the plasma membrane through distinct pathways in 3T3L1 adipocytes (D. Chen, J. S. Elmendorf, A. L. Olson, X. Li, H. S. Earp, and J. E. Pessin, J. Biol. Chem. 272:27401-27410, 1997). In investigations of the relationships between these two signaling pathways, we have now observed that these two stimuli are not additive, and, in fact, osmotic shock pretreatment was found to completely prevent any further insulin stimulation of glucose transport activity and GLUT4 protein translocation. In addition, osmotic shock inhibited the insulin stimulation of lipogenesis and glycogen synthesis. This inhibition of insulin-stimulated downstream signaling occurred without any significant effect on insulin receptor autophosphorylation or tyrosine phosphorylation of insulin receptor substrate 1 (IRS1). Furthermore, there was no effect on either the insulin-stimulated association of the p85 type I phosphatidylinositol (PI) 3-kinase regulatory subunit with IRS1 or phosphotyrosine antibody-immunoprecipitated PI 3-kinase activity. In contrast, osmotic shock pretreatment markedly inhibited the insulin stimulation of protein kinase B (PKB) and p70S6 kinase activities. In addition, the dephosphorylation of PKB was prevented by pretreatment with the phosphatase inhibitors okadaic acid and calyculin A. These data support a model in which osmotic shock-induced insulin resistance of downstream biological responses results from an inhibition of insulin-stimulated PKB activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373517      PMCID: PMC84266          DOI: 10.1128/MCB.19.7.4684

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B.

Authors:  D Stokoe; L R Stephens; T Copeland; P R Gaffney; C B Reese; G F Painter; A B Holmes; F McCormick; P T Hawkins
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

Review 2.  The insulin signalling system and the IRS proteins.

Authors:  M F White
Journal:  Diabetologia       Date:  1997-07       Impact factor: 10.122

3.  Insulin stimulates p70 S6 kinase in the nucleus of cells.

Authors:  S J Kim; C R Kahn
Journal:  Biochem Biophys Res Commun       Date:  1997-05-29       Impact factor: 3.575

4.  Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue.

Authors:  D A Cross; P W Watt; M Shaw; J van der Kaay; C P Downes; J C Holder; P Cohen
Journal:  FEBS Lett       Date:  1997-04-07       Impact factor: 4.124

5.  Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

Authors:  H B Jefferies; S Fumagalli; P B Dennis; C Reinhard; R B Pearson; G Thomas
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes.

Authors:  H Sakaue; W Ogawa; M Takata; S Kuroda; K Kotani; M Matsumoto; M Sakaue; S Nishio; H Ueno; M Kasuga
Journal:  Mol Endocrinol       Date:  1997-09

7.  A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family.

Authors:  B E Lavan; V R Fantin; E T Chang; W S Lane; S R Keller; G E Lienhard
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

8.  Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes.

Authors:  J F Tanti; S Grillo; T Grémeaux; P J Coffer; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Endocrinology       Date:  1997-05       Impact factor: 4.736

9.  The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family.

Authors:  B E Lavan; W S Lane; G E Lienhard
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

10.  Insulin-stimulated disassociation of the SOS-Grb2 complex.

Authors:  S B Waters; K Yamauchi; J E Pessin
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

View more
  18 in total

1.  Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine.

Authors:  Elango Kathirvel; Kengathevy Morgan; Ganesh Nandgiri; Brian C Sandoval; Marie A Caudill; Teodoro Bottiglieri; Samuel W French; Timothy R Morgan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

2.  Protein phosphatase 2A acts as a mitogen-activated protein kinase kinase kinase 3 (MEKK3) phosphatase to inhibit lysophosphatidic acid-induced IkappaB kinase beta/nuclear factor-kappaB activation.

Authors:  Wenjing Sun; Hao Wang; Xiumei Zhao; Yang Yu; Yihui Fan; Hao Wang; Xishan Wang; Xiongbin Lu; Guiyin Zhang; Songbin Fu; Jianhua Yang
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

3.  The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2.

Authors:  Kristi J Warren; Xi Fang; Nagaraj M Gowda; Joshua J Thompson; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-10-14       Impact factor: 5.157

4.  Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase.

Authors:  M Andjelković; S M Maira; P Cron; P J Parker; B A Hemmings
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.

Authors:  Dong Chen; Scott Reierstad; Feng Fang; Serdar E Bulun
Journal:  Mol Endocrinol       Date:  2011-03-10

Review 6.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

7.  Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis.

Authors:  Yong Liao; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Streptolysin S Promotes Programmed Cell Death and Enhances Inflammatory Signaling in Epithelial Keratinocytes during Group A Streptococcus Infection.

Authors:  Rebecca A Flaherty; Jessica M Puricelli; Dustin L Higashi; Claudia J Park; Shaun W Lee
Journal:  Infect Immun       Date:  2015-08-03       Impact factor: 3.441

9.  Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.

Authors:  Mohammad Reza Lornejad-Schäfer; Christine Schäfer; Dirk Graf; Dieter Häussinger; Freimut Schliess
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

10.  Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta.

Authors:  R Ben-Romano; A Rudich; A Tirosh; R Potashnik; T Sasaoka; K Riesenberg; F Schlaeffer; N Bashan
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.